Irene
Gañan Gomez
Investigadora
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublications en collaboration avec des chercheurs de Washington University in St. Louis School of Medicine (2)
2022
-
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4)
Nature Medicine
-
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
Nature Medicine, Vol. 28, Núm. 3, pp. 557-567